Cases of aspergillosis have been increasingly reported in patients receiving monoclonal antibodies [28,29], small-molecule protein kinases inhibitors [30,31], agents for autoimmune disorders, and novel immunotherapies [32,33]. Here, WEE1 is linked to aspergillosis.